# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5176197 | 10b; [(RS)-EHPMPT] | CC50 | > | 100 | uM | ALA5124940 | nM | Homo sapiens | |||
2. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC90 | > | 100 | uM | ALA5124938 | uM | Hepatitis B virus | |||
3. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC50 | > | 100 | uM | ALA5124938 | nM | Hepatitis B virus | |||
4. | ALA5176197 | 10b; [(RS)-EHPMPT] | Ratio CC50/EC50 | = | 1 | ALA5124937 | ||||||
5. | ALA5176197 | 10b; [(RS)-EHPMPT] | Ratio CC50/EC50 | = | 1 | ALA5124936 | ||||||
6. | ALA5176197 | 10b; [(RS)-EHPMPT] | CC50 | > | 392.81 | uM | ALA5124935 | nM | Homo sapiens | |||
7. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC50 | > | 392.81 | uM | ALA5124934 | nM | Human immunodeficiency virus 2 | |||
8. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC50 | > | 392.81 | uM | ALA5124933 | nM | Human immunodeficiency virus 1 | |||
9. | ALA5176197 | 10b; [(RS)-EHPMPT] | Ratio CC50/EC50 | = | 5 | ALA5124932 | ||||||
10. | ALA5176197 | 10b; [(RS)-EHPMPT] | CC50 | = | 138.88 | uM | ALA5124931 | nM | Homo sapiens | |||
11. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC90 | > | 30 | uM | ALA5124930 | uM | Human alphaherpesvirus 3 | |||
12. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC50 | = | 27.07 | uM | ALA5124930 | 4.57 | nM | Human alphaherpesvirus 3 | ||
13. | ALA5176197 | 10b; [(RS)-EHPMPT] | Ratio CC50/EC50 | < | 5 | ALA5124929 | ||||||
14. | ALA5176197 | 10b; [(RS)-EHPMPT] | CC50 | = | 140.16 | uM | ALA5124928 | nM | Homo sapiens | |||
15. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC90 | > | 30 | uM | ALA5124927 | uM | Human betaherpesvirus 5 | |||
16. | ALA5176197 | 10b; [(RS)-EHPMPT] | EC50 | = | 30 | uM | ALA5124927 | 4.52 | nM | Human betaherpesvirus 5 |